MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025)
MeiraGTx Holdings (MGTX) reported Amortizatization of Intangibles of $991000.0 for Q4 2025, up 261.14% on a YoY basis from $274410.2 in Q4 2024, and up 332.63% quarter-over-quarter from -$426000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Amortizatization of Intangibles for 4 years, with the latest figure at $991000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 261.14% year-over-year to $991000.0; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (up 434.45% YoY), and the FY2025 full-year result was $1.1 million, up 434.45% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $991000.0, up from -$426000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $991000.0 in Q4 2025, with the low at -$615000.0 in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $185153.8 across 4 years, with a median of $48000.0 in 2024.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles soared 47750.0% — and 2025, when it plunged 253.24%.
- MeiraGTx Holdings' Amortizatization of Intangibles stood at -$2000.0 in 2022, then soared by 47750.0% to $953000.0 in 2023, then tumbled by 164.53% to -$615000.0 in 2024, then jumped by 261.14% to $991000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $991000.0 (Q4 2025), -$426000.0 (Q3 2025), and $489000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 991,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 991,000.00 |
| Dec 31, 2025 | 991,000.00 |
| Sep 30, 2025 | -426,000.00 |
| Sep 30, 2025 | -426,000.00 |
| Jun 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 489,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2024 | -615,000.00 |
| Dec 31, 2024 | -615,000.00 |
| Sep 30, 2024 | 278,000.00 |
| Sep 30, 2024 | 278,000.00 |
| Jun 30, 2024 | 498,000.00 |
| Jun 30, 2024 | 498,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 953,000.00 |
| Dec 31, 2023 | 953,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |